Active ingredientMiltefosineCat. No. P-M133-001CAS 58066-85-6Family · Pharmaceutical analytical standards
Miltefosine
An alkylphosphocholine born in the early 1980s as a potential anticancer drug and then developed against leishmaniasis: approved in India in 2002 as the first oral medicine for this disease, and in the United States in 2014. This family brings together the active ingredient and labelled standards.
Did you know?It is also used against free-living amoebae such as Naegleria fowleri, the so-called brain-eating amoeba: in 2013 the US CDC recommended it for these rare brain infections.
Go to the active ingredient →Active ingredientMiltefosineCat. No. P-M133-001CAS 58066-85-6
Isotopically labelledMiltefosine-d9Cat. No. P-M133-002No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.